View in EDS

Current status and perspective of immunotherapy for head and neck squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: Current status and perspective of immunotherapy for head and neck squamous cell carcinoma.
Authors: Vitale P; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy., Di Giovanni I; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy., Tammaro C; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy.; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy., Spedaliere R; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy., Amler E; Department of Natural Sciences, Faculty of Biomedical Engineering, Czech Technical University in Prague, Prague, Czech Republic., Necas A; Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Brno, Czech Republic., Scrima M; Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic Research, Ariano Irpino, Italy., Caraglia M; Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.; Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic Research, Ariano Irpino, Italy., Addeo R; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy.
Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2026 Jan-Feb; Vol. 35 (2), pp. 151-168. Date of Electronic Publication: 2026 Feb 09.
Publication Type: Journal Article; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-7658
DOI:10.1080/13543784.2026.2627205